Research Title: A Multiple-Center, Multiple-Dose and Regimen, Randomized, Active Comparator Controlled, Double-Masked, Parallel Group, 36 Week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RG7716 Administered Intravitreally in Patients With Choroidal Neovascularization Secondary to Age-Related Macular Degeneration.
Sponsor: Hoffmanm-La Roche
Principal Investigator: Jay Stallman, M.D., F.A.C.S.
Description: This study will evaluate the safety, tolerability, pharmacokinetics, and efficacy of RG7716 in participants with subfoveal CNV secondary to AMD.
Start Date: December 2015
Project Personnel: Leslie Marcus, CCRC; Caitlin Harrison, COA; Halie Sklanka, CRC
Location(s): Tucker; 1462 Montreal Road West, Suite 412, Tucker, GA 30084